
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Chidamide and cytarabine synergistically treat acute myeloid leukemia: inhibiting ribosome biogenesis via the MYC-RRP9 pathway - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="4DDE488889B73D631B48880032D80F6B.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="cddis">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334614/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Cell Death &amp; Disease">
<meta name="citation_title" content="Chidamide and cytarabine synergistically treat acute myeloid leukemia: inhibiting ribosome biogenesis via the MYC-RRP9 pathway">
<meta name="citation_author" content="Qing Li">
<meta name="citation_author_institution" content="Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China">
<meta name="citation_author" content="Fangfang Wang">
<meta name="citation_author_institution" content="Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China">
<meta name="citation_author" content="Xinrong Xiang">
<meta name="citation_author_institution" content="Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China">
<meta name="citation_author" content="Lei Zhao">
<meta name="citation_author_institution" content="Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China">
<meta name="citation_author" content="Xuefeng Li">
<meta name="citation_author_institution" content="Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China">
<meta name="citation_author" content="Ying Qu">
<meta name="citation_author_institution" content="Department of Hematology and Institute of Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan China">
<meta name="citation_author" content="Jingcao Huang">
<meta name="citation_author_institution" content="Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China">
<meta name="citation_author" content="Yunfan Yang">
<meta name="citation_author_institution" content="Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China">
<meta name="citation_author" content="Yang Dai">
<meta name="citation_author_institution" content="Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China">
<meta name="citation_author" content="Xiao Shuai">
<meta name="citation_author_institution" content="Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China">
<meta name="citation_author" content="Jiazhuo Liu">
<meta name="citation_author_institution" content="Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China">
<meta name="citation_author" content="Jie Huang">
<meta name="citation_author_institution" content="Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China">
<meta name="citation_author" content="Yu Liu">
<meta name="citation_author_institution" content="Department of Hematology and Institute of Hematology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan China">
<meta name="citation_author" content="Yu Wu">
<meta name="citation_author_institution" content="Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China">
<meta name="citation_publication_date" content="2025 Aug 9">
<meta name="citation_volume" content="16">
<meta name="citation_issue" content="1">
<meta name="citation_firstpage" content="601">
<meta name="citation_doi" content="10.1038/s41419-025-07928-y">
<meta name="citation_pmid" content="40781078">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334614/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334614/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334614/pdf/41419_2025_Article_7928.pdf">
<meta name="description" content="This study explores innovative therapeutic approaches for acute myeloid leukemia by examining the synergistic effects of the histone deacetylase inhibitor chidamide in combination with cytarabine. In both in vitro and in vivo models, the drug ...">
<meta name="og:title" content="Chidamide and cytarabine synergistically treat acute myeloid leukemia: inhibiting ribosome biogenesis via the MYC-RRP9 pathway">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="This study explores innovative therapeutic approaches for acute myeloid leukemia by examining the synergistic effects of the histone deacetylase inhibitor chidamide in combination with cytarabine. In both in vitro and in vivo models, the drug ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334614/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Searchâ€¦
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12334614">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s41419-025-07928-y"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/41419_2025_Article_7928.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12334614%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12334614/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12334614/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334614/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-cddis.gif" alt="Cell Death &amp; Disease logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Cell Death &amp; Disease" title="Link to Cell Death &amp; Disease" shape="default" href="http://www.nature.com/cddis/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Cell Death Dis</button></div>. 2025 Aug 9;16(1):601. doi: <a href="https://doi.org/10.1038/s41419-025-07928-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s41419-025-07928-y</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Cell%20Death%20Dis%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cell%20Death%20Dis%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cell%20Death%20Dis%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Cell%20Death%20Dis%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Chidamide and cytarabine synergistically treat acute myeloid leukemia: inhibiting ribosome biogenesis via the MYC-RRP9 pathway</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Q%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Qing Li</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Qing Li</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Q%22%5BAuthor%5D" class="usa-link"><span class="name western">Qing Li</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Fangfang Wang</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Fangfang Wang</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fangfang Wang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xiang%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Xinrong Xiang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Xinrong Xiang</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xiang%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xinrong Xiang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Lei Zhao</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Lei Zhao</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lei Zhao</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Xuefeng Li</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Xuefeng Li</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xuefeng Li</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qu%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Ying Qu</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Ying Qu</span></h3>
<div class="p">
<sup>2</sup>Department of Hematology and Institute of Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qu%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Ying Qu</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Jingcao Huang</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Jingcao Huang</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jingcao Huang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Yunfan Yang</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Yunfan Yang</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yunfan Yang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dai%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Yang Dai</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Yang Dai</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dai%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yang Dai</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shuai%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Xiao Shuai</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Xiao Shuai</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shuai%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiao Shuai</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Jiazhuo Liu</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Jiazhuo Liu</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jiazhuo Liu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Jie Huang</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Jie Huang</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jie Huang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Yu Liu</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Yu Liu</span></h3>
<div class="p">
<sup>3</sup>Department of Hematology and Institute of Hematology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yu Liu</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Yu Wu</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Yu Wu</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yu Wu</span></a>
</div>
</div>
<sup>1,</sup><sup>âœ‰</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan China </div>
<div id="Aff2">
<sup>2</sup>Department of Hematology and Institute of Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan China </div>
<div id="Aff3">
<sup>3</sup>Department of Hematology and Institute of Hematology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan China </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>âœ‰</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Jan 17; Revised 2025 Jul 1; Accepted 2025 Jul 30; Collection date 2025 Dec.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Â© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the articleâ€™s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the articleâ€™s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12334614Â Â PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40781078/" class="usa-link">40781078</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">This study explores innovative therapeutic approaches for acute myeloid leukemia by examining the synergistic effects of the histone deacetylase inhibitor chidamide in combination with cytarabine. In both in vitro and in vivo models, the drug combination demonstrated significant synergism in combating acute myeloid leukemia. Transcriptomic analysis revealed that the combination treatment notably downregulates the MYC signaling pathway. Binding assays, including surface plasmon resonance, molecular docking, and molecular dynamics simulations, further demonstrated that chidamide directly interacts with the C-MYC protein, while cytarabine enhanced this interaction. Delving deeper into the mechanism, we identified <em>RRP9</em>â€”an essential gene for ribosome biogenesis and a key player in acute myeloid leukemia prognosisâ€”as a critical component of the MYC pathway. It was confirmed that MYC regulates RRP9 expression. Functional assays showed that overexpression of RRP9 promoted acute myeloid leukemia cell proliferation and resistance to the chidamide-cytarabine combination, whereas RRP9 knockdown impaired rRNA synthesis, reduced nucleolar size, and diminished protein production. Ultimately, we found that chidamide combined with cytarabine effectively inhibit ribosome biogenesis in acute myeloid leukemia cells. These results underscore the therapeutic potential of targeting the MYC-RRP9 axis to disrupt ribosome biogenesis in acute myeloid leukemia, offering a promising avenue for acute myeloid leukemia treatment.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Subject terms:</strong> Acute myeloid leukaemia, Acute myeloid leukaemia</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par2">Acute myeloid leukemia (AML) is a heterogeneous malignancy marked by the uncontrolled proliferation of clonal hematopoietic cells [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. The overall 5-year survival rates in patients with AML were 28% in the decades 2010 to 2017 [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. Since 2017, twelve new drugs, including targeted therapies such as venetoclax, FLT3 inhibitors, IDH inhibitors, and epigenetic modifiers, have been approved for AML treatment [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. Increasing research is focusing on integrating these targeted therapies with the conventional â€œ3â€‰+â€‰7â€ chemotherapy regimen [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. These innovations have enabled personalized and targeted treatment in AML, improving patient outcomes and quality of life [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. Nevertheless, the overall survival rate remains stagnant, underscoring the pressing need for innovative therapeutic strategies.</p>
<p id="Par3">Chidamide (CS055), a novel oral histone deacetylase (HDAC) inhibitor targeting HDAC1, 2, 3, and 10, induces tumor cell cycle arrest, promotes apoptosis, and enhances antitumor immunity. Approved by the Chinese FDA in 2014 for peripheral T-cell lymphoma [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>], it received expanded approval in 2024 for treating newly diagnosed diffuse large B-cell lymphoma with dual MYC and BCL2 expression. Chidamide, when combined with AML treatments like daunorubicin, decitabine, or the CAG regimen (cytarabine, aclarubicin, and granulocyte colony stimulating factor), has shown significant therapeutic potential [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>â€“<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. Clinical trials have reported a complete remission rate of 45% with the chidamide and CAG regimen in patients with relapsed AML/MDS [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. Another multicenter study confirmed an overall response rate of 46.2% when chidamide was paired with epigenetic modifiers and standard chemotherapy [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. These findings underline its promising efficacy in AML therapy, though mechanisms remain unclear.</p>
<p id="Par4">Dysregulated ribosome biogenesis, a hallmark of various cancers including AML, fuels unchecked cellular growth and proliferation, ultimately driving disease progression and correlating with unfavorable patient outcomes [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>â€“<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. Ribosome biogenesis is a multi-stage process beginning in the nucleolus and culminating in ribosome assembly. Nucleolar shape, size, and number correlate with ribosome production efficiency and the cellâ€™s metabolic and proliferation status [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. Nucleophosmin 1 (NPM1), located in the nucleolus, is involved in ribosome biogenesis [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. Ribosomal DNA is transcribed into 47S pre-rRNA, which is processed into 5.8S, 18S, and 28S rRNAs [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. RRP9, a subunit of the U3 small nucleolar ribonucleoproteins (snoRNPs), is essential for early pre-rRNA cleavage at the A0, A1, and A2 sites [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. Database analyses show a strong correlation between elevated RRP9 expression and poorer AML prognosis [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. However, its regulatory mechanisms and precise role in AML progression remain largely unexplored.</p>
<p id="Par5">Preclinical studies suggest that targeting ribosome biogenesis or protein synthesis shows promising efficacy in AML treatment [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>, <a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. CX-5461, a selective ribosomal DNA transcription inhibitor, has demonstrated antitumor activity and long-term safety in hematological malignancies [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]. MYC, a key regulator of ribosome biogenesis and protein synthesis, is a well-established proto-oncogene involved in production of ribosomal components [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>, <a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. Furthermore, studies have demonstrated that MYC enhances the survival of leukemia stem cells [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. HDAC inhibitors have shown promise in targeting MYC-driven cancers [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. This study aims to assess the therapeutic effects of HDAC inhibitors chidamide combined with cytarabine in AML, focusing on their ability to inhibit ribosome biogenesis via the MYC pathway. This approach seeks to provide new insights and potential targets for AML treatment.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Synergistic therapeutic effects of chidamide and cytarabine in AML cells</h3>
<p id="Par6">We assessed the toxicity of chidamide and cytarabine on MV4-11 and Kasumi-1 cells using the MTT assay. Both chidamide and cytarabine inhibited the growth of AML cell lines in a dose- and time-dependent manner (Fig. <a href="#MOESM2" class="usa-link">S1Aâ€“L</a>). The half-maximal inhibitory concentrations (IC50) of chidamide and cytarabine at 24, 48, and 72â€‰hours are presented in Table <a href="#MOESM2" class="usa-link">S1</a>. Notably, the combination of chidamide and cytarabine induced greater cell death in MV4-11 and Kasumi-1 cells compared to either drug alone (Fig. <a href="#Fig1" class="usa-link">1A, B</a>), and a similar effect was observed in HL60 cells (Fig. <a href="#MOESM2" class="usa-link">S2A</a>). Combination index (CI) values were calculated using CompuSyn based on the Chou-Talalay method to assess drug interaction. A CIâ€‰&lt;â€‰1 indicates synergy, =1 additive effect, and &gt;1 antagonism. In MV4-11 and Kasumi-1 cells, all CI values were &lt;1, indicating synergistic effects between chidamide and cytarabine (Fig. <a href="#Fig1" class="usa-link">1C, D</a>). Synergistic effects were also observed in HL60 cells (Fig. <a href="#MOESM2" class="usa-link">S2B</a>).</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1. Synergistic therapeutic effects of chidamide and cytarabine in AML cells.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334614_41419_2025_7928_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af7/12334614/c15aa6dff782/41419_2025_7928_Fig1_HTML.jpg" loading="lazy" id="d33e466" height="757" width="800" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong>, <strong>B</strong> Cytotoxic effects of chidamide and cytarabine, alone or in combination, on MV4-11 cells (left) and Kasumi-1 cells (right). <strong>C</strong>, <strong>D</strong> Combination index plot, the horizontal axis (Fa) represents the inhibition rate, while the vertical axis shows CI values. <strong>E</strong>, <strong>F</strong> In MV4-11 cells, significant differences were observed between chidamide and combination (<em>P</em>â€‰=â€‰0.0055) and between cytarabine and combination (<em>P</em>â€‰=â€‰0.0014). In Kasumi-1 cells, both comparisons were also significant (chidamide vs. combination: <em>P</em>â€‰=â€‰0.0002; cytarabine vs. combination: <em>P</em>â€‰=â€‰0.0005; unpaired t-test). <strong>G</strong>, <strong>H</strong> Western blot analysis of cleaved caspase-3, cleaved caspase-9, BCL-2, and BCL-XL in MV4-11 (left) and Kasumi-1 (right) cells. For MV4-11: ARA-C vs. combination (<em>P</em>â€‰=â€‰0.0019, 0.0468, 0.0013, 0.0003); chidamide vs. combination (<em>P</em>â€‰=â€‰0.0071, 0.0463, 0.0013, 0.0018). For Kasumi-1: ARA-C vs. combination (<em>P</em>â€‰=â€‰0.0063, 0.0021, 0.0420, 0.0027); chidamide vs. combination (<em>P</em>â€‰=â€‰0.0397, 0.0077, 0.0140, 0.0120) (unpaired t-test). CTR (control), Chi (chidamide), ARA-C (cytarabine), Chi+ARA-C (chidamide + cytarabine); cCASP3, cleaved Caspase-3; cCASP9, cleaved Caspase-9. *<em>P</em>â€‰&lt;â€‰0.05, **<em>P</em>â€‰&lt;â€‰0.01, ***<em>P</em>â€‰&lt;â€‰0.001.</p></figcaption></figure><p id="Par7">We employed flow cytometry to assess apoptosis induction in AML cell lines treated with the combination of chidamide and cytarabine. Compared to cytarabine monotherapy, the percentage of apoptotic MV4-11 cells increased from 25.11% Â± 1.69% to 79.65% Â± 2.33% (Fig. <a href="#Fig1" class="usa-link">1E</a>), and that of Kasumi-1 cells rose from 11.99% Â± 0.75% to 39.18% Â± 0.35% (Fig. <a href="#Fig1" class="usa-link">1F</a>) after 48â€‰hours of co-treatment. In HL60 cells, apoptosis increased from 2.98% Â± 0.24% to 39.45% Â± 0.92% (Fig. <a href="#MOESM2" class="usa-link">S2C</a>).</p>
<p id="Par8">Western blot analysis revealed that the chidamide-cytarabine combination significantly upregulated the expression of cleaved Caspase-3 and cleaved Caspase-9, while downregulating BCL-2 and BCL-XL in both MV4-11 cells (Fig. <a href="#Fig1" class="usa-link">1G</a>) and Kasumi-1 cells (Fig. <a href="#Fig1" class="usa-link">1H</a>). Similar changes were also observed in HL60 cells (Fig. <a href="#MOESM2" class="usa-link">S2D</a>). Furthermore, western blot showed that the combination treatment significantly enhanced histone acetylation, increasing levels of ace-H3K9, ace-H3K18, and ace-H4K16 in both MV4-11 cells (Fig. <a href="#MOESM2" class="usa-link">S3A</a>) and Kasumi-1 cells (Fig. <a href="#MOESM2" class="usa-link">S3B</a>).</p></section><section id="Sec4"><h3 class="pmc_sec_title">Synergistic therapeutic effects of chidamide and cytarabine in AML in vivo</h3>
<p id="Par9">We employed the CCK-8 assay to evaluate the cytotoxic effect of chidamide combined with cytarabine on primary AML cells. The combination treatment demonstrated a stronger inhibition on primary AML cells from six patients compared to either drug alone (Fig. <a href="#Fig2" class="usa-link">2Aâ€“F</a>). Across the tested concentration ranges, the CI remained below 1 (Fig. <a href="#Fig2" class="usa-link">2Gâ€“L</a>), confirming the synergistic cytotoxicity of chidamide and cytarabine. Clinical details of the six AML patients are provided in Table <a href="#MOESM2" class="usa-link">S2</a>. We established an AML xenograft mouse model by intravenously injecting immunodeficient mice with MV4-11-luciferase-GFP cells, which were generated by infecting MV4-11 cells with lentivirus carrying both luciferase and GFP, to investigate the in vivo synergistic therapeutic potential of the drug combination. Over the treatment period, the fluorescence intensity difference between treatment groups became increasingly pronounced. Chidamide monotherapy significantly reduced tumor burden, while its combination with cytarabine achieved an even greater reduction (Fig. <a href="#Fig2" class="usa-link">2M</a>).</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2. Synergistic therapeutic effects of chidamide and cytarabine in AML in vivo.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334614_41419_2025_7928_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af7/12334614/d8302a09979a/41419_2025_7928_Fig2_HTML.jpg" loading="lazy" id="d33e543" height="539" width="790" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong>â€“<strong>F</strong> Cytotoxic effects of chidamide and cytarabine alone or in combination on PBMCs from 6 AML patients. <strong>G</strong>â€“<strong>L</strong> Combination index plot of 6 patients, the horizontal axis (Fa) represents the inhibition rate, while the vertical axis shows CI values. <strong>M</strong> In vivo images of mice on days 7, 14, and 19 after treatment with control, chidamide, cytarabine, or their combination. Fluorescence intensities were quantified using Living Image software. Statistical analysis (unpaired t-test) with GraphPad Prism 8.0 showed significant differences between control and chidamide or chidamide + cytarabine groups (<em>P</em>â€‰=â€‰0.0086 and 0.0020, respectively) (<em>n</em>â€‰â€‰=â€‰5). CTR (control), Chi (chidamide), ARA-C (cytarabine), Chi+ARA-C (chidamide+ cytarabine). **<em>P</em>â€‰&lt;â€‰0.01.</p></figcaption></figure><p id="Par10">In clinical practice, we registered the clinical trial of chidamide for the treatment of AML with the Chinese Clinical Trial Registry (<a href="https://www.chictr.org.cn/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.chictr.org.cn/</a>) (registration number ChiCTR2300073732), and five AML patients previously enrolled received chidamide-based treatment (20â€‰mg twice a week). Notably, this regimen achieved complete remission (CR) in both high-risk patients at diagnosis (patients 1 and 2) and relapsed patients (patients 3 and 4). In addition, in a patient with persistent minimal residual disease (MRD) positivity (patient 5), MRD was successfully converted to negative for 13 months. Detailed patient data are shown in Table <a href="#MOESM2" class="usa-link">S3</a>. Enrollment in this clinical trial is ongoing.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Chidamide combined with cytarabine synergistically suppresses the MYC signaling pathway</h3>
<p id="Par11">To investigate the synergistic mechanisms of chidamide and cytarabine in AML, transcriptome sequencing (RNA-seq) was performed on MV4-11 cells, a human AML cell line harboring FLT3-ITD mutation and t(4;11) translocation. The combination treatment significantly downregulated the MYC signaling pathway (Fig. <a href="#Fig3" class="usa-link">3A</a>). Notably, this inhibition was more pronounced with the combination treatment than with either drug alone (Fig. <a href="#MOESM2" class="usa-link">S4A, B</a>). We further quantified MYC mRNA levels by quantitative real-time PCR (qPCR) in peripheral blood mononuclear cells (PBMCs) from 17 AML patients and 17 healthy controls, revealing significantly higher expression in AML patients (Fig. <a href="#Fig3" class="usa-link">3B</a>). Consistently, analysis of Gene Expression Profiling Interactive Analysis 2 (GEPIA2) data demonstrated that high MYC expression is associated with poorer prognosis in AML patients (Fig. <a href="#Fig3" class="usa-link">3C</a>). Western blot analysis showed that the combination treatment more effectively suppressed c-MYC protein levels in MV4-11 cells than either single agent alone (Fig. <a href="#Fig3" class="usa-link">3D</a>), even in the presence of the proteasome inhibitor MG132 (Fig. <a href="#Fig3" class="usa-link">3E</a>). Consistent results were also observed in HL60 cells (Fig. <a href="#MOESM2" class="usa-link">S4C, D</a>).</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3. Chidamide combined with cytarabine synergistically suppresses the MYC signaling pathway.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334614_41419_2025_7928_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af7/12334614/c18d8913c16b/41419_2025_7928_Fig3_HTML.jpg" loading="lazy" id="d33e645" height="821" width="800" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> Compared with the control group, the MYC pathway was significantly downregulated in the chidamide combined with cytarabine group. <strong>B</strong>
<em>MYC</em> mRNA levels in PBMCs from AML patients and healthy individuals (<em>P</em>â€‰=â€‰0.0089, unpaired t-test) (<em>n</em>â€‰=â€‰17). <strong>C</strong> Data from the GEPIA2 website showing that high MYC expression in AML patients is significantly associated with poor prognosis (<em>P</em>â€‰=â€‰0.0260, Kaplan Meier analysis), cutoff-high (15%), cutoff-low (85%). <strong>D</strong> Effects of chidamide and cytarabine on c-MYC protein levels in MV4-11 cells, with quantification of the results. Significant difference between cytarabine and combination (<em>P</em>â€‰=â€‰0.0031, unpaired t-test). <strong>E</strong> c-MYC protein levels in MV4-11 cells were evaluated and quantified after treatment with chidamide and cytarabine in the presence of MG132. Significant difference between cytarabine and combination (<em>P</em>â€‰=â€‰0.0026, unpaired t-test). <strong>F</strong> SPR assay demonstrating chidamideâ€™s affinity for c-MYC recombinant protein. <strong>G</strong> SPR assay showing the effect of 10â€‰ÂµM cytarabine on chidamideâ€™s affinity for c-MYC recombinant protein. <strong>H</strong>, <strong>I</strong> Two-dimensional (left) and three-dimensional (right) representations of molecular docking between chidamide and the MYC-MAX complex. <strong>J</strong> SPR analysis showing binding affinity of chidamide to MYC protein carrying point mutations at the predicted binding sites. <strong>K</strong><strong>â€“N</strong> Simulation of chidamide binding to the MYC protein, with or without cytarabine, illustrating RMSD, SASA, Rg, and hydrogen bond (from left to right) dynamics over time. CTR (control), Chi (chidamide), ARA-C (cytarabine), Chi+ARA-C (chidamide + cytarabine). **<em>P</em>â€‰&lt;â€‰0.01.</p></figcaption></figure><p id="Par12">Surface plasmon resonance (SPR) assay experiments were performed to assess chidamide binding to recombinant c-MYC, using 10058-F4 as a positive control, which showed concentration-dependent binding (Fig. <a href="#MOESM2" class="usa-link">S4E</a>). Using this validated assay, chidamide was shown to bind to c-MYC in a concentration-dependent manner. In a pure buffer system, the dissociation constant (Kd) was determined to be 7.953E-7 M (Fig. <a href="#Fig3" class="usa-link">3F</a>). Notably, in the presence of 10â€‰Î¼M cytarabine, the Kd decreased to 1.704E-7 M (Fig. <a href="#Fig3" class="usa-link">3G</a>), suggesting enhanced binding affinity of chidamide to c-MYC.</p>
<p id="Par13">Molecular docking analysis showed that LYS945 of MYC forms a hydrogen bond with chidamide, while PRO938, VAL941, and ALA948 of MYC establish Pi-Alkyl interactions. Additionally, LEU210 of MAX forms a Pi-Sigma interaction (Fig. <a href="#Fig3" class="usa-link">3H, I</a>).</p>
<p id="Par14">In the docking of cytarabine with the chidamide-MYC-MAX complex, cytarabine interacts with ASP220 and ARG212 of MAX through hydrogen bonds, with ASP216 and LYS213 via carbon-hydrogen bonds, and with ASP220 through a Pi-anion interaction (Fig. <a href="#MOESM2" class="usa-link">S4F, G</a>). To confirm the predicted binding sites, MYC protein with point mutations were generated. Compared to wild-type MYC, the mutant proteins showed significantly reduced binding affinity for chidamide, with a Kd value of 3.116E-6 M (Fig. <a href="#Fig3" class="usa-link">3J</a>).</p>
<p id="Par15">Molecular dynamics (MD) simulations were performed to evaluate whether the combination of chidamide and cytarabine binds more effectively to the MYCâ€“MAX complex than either drug alone. After 25â€‰ns of simulation, both proteinâ€“ligand complexes reached equilibrium, demonstrating the stability and reliability of the models. Notably, the cytarabineâ€“chidamideâ€“MYCâ€“MAX complex displayed a lower RMSD than the chidamideâ€“MYCâ€“MAX complex, suggesting that the dual-drug combination confers greater binding stability to the MYCâ€“MAX complex (Fig. <a href="#Fig3" class="usa-link">3K</a>). Throughout the simulations, the solvent-accessible surface area (SASA) of the proteinâ€“ligand complexes gradually decreased, reflecting enhanced protein compactness. Moreover, the SASA of the chidamideâ€“MYCâ€“MAX complex fluctuated more than that of the cytarabineâ€“chidamideâ€“MYCâ€“MAX complex, suggesting improved stability with the dual-drug combination (Fig. <a href="#Fig3" class="usa-link">3L</a>). Similarly, the radius of gyration (Rg) steadily decreased during the simulations, indicating a more compact protein structure. The Rg of the chidamideâ€“MYCâ€“MAX complex showed greater fluctuation than that of the cytarabineâ€“chidamideâ€“MYCâ€“MAX complex, consistent with the SASA results and further supporting the enhanced stability of the dual-drug combination (Fig. <a href="#Fig3" class="usa-link">3M</a>). Additionally, the average number of hydrogen bonds was 0.206 in the chidamideâ€“MYCâ€“MAX complex and 1.41 in the cytarabineâ€“chidamideâ€“MYCâ€“MAX complex, indicating stronger hydrogen bonding in the dual-drug system (Fig. <a href="#Fig3" class="usa-link">3N</a>). The binding free energies for the chidamideâ€“MYCâ€“MAX and cytarabineâ€“chidamideâ€“MYCâ€“MAX complexes were calculated to be âˆ’141.672â€‰kJ/mol and âˆ’234.619â€‰kJ/mol, respectively, with electrostatic and van der Waals interactions serving as the primary contributors (Table <a href="#MOESM2" class="usa-link">S4</a>).</p></section><section id="Sec6"><h3 class="pmc_sec_title">The MYC signaling pathway drives the upregulation of RRP9 expression in AML</h3>
<p id="Par16">RNA-seq revealed that ribosome assembly factors were enriched in the MYC pathway (Fig. <a href="#Fig3" class="usa-link">3A</a>). We further analyzed the expression of specific ribosome assembly factorsâ€”<em>RRP9</em>, <em>NOP16</em>, <em>NOP56</em>, and <em>DDX21</em>â€”in AML patients and healthy controls. Among them, only <em>RRP9</em> was significantly upregulated in AML patients (Fig. <a href="#Fig4" class="usa-link">4A</a>), whereas <em>NOP16</em> and <em>NOP56</em> showed no significant changes (Fig. <a href="#MOESM2" class="usa-link">S5A</a>, <a href="#MOESM2" class="usa-link">B</a>), and <em>DDX21</em> was downregulated (Fig. <a href="#MOESM2" class="usa-link">S5C</a>). To further explore MYC regulation of RRP9, we generated MYC-overexpressing and MYC-knockdown cell models. Western blot analysis showed that RRP9 protein levels increased with MYC overexpression (Fig. <a href="#Fig4" class="usa-link">4B</a>) and decreased with MYC knockdown (Fig. <a href="#Fig4" class="usa-link">4C</a>), consistent with c-MYC expression.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4. The MYC signaling pathway drives the upregulation of RRP9 expression in AML.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334614_41419_2025_7928_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af7/12334614/23d85ad728ac/41419_2025_7928_Fig4_HTML.jpg" loading="lazy" id="d33e801" height="343" width="790" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong>
<em>RRP9</em> mRNA levels in PBMCs from AML patients and healthy individuals (<em>P</em>â€‰=â€‰0.0019, unpaired t-test) (<em>n</em>â€‰=â€‰19). <strong>B</strong> Western blot of c-MYC and RRP9 in MYC-overexpressing vs. control cells. Expression levels were significantly different for c-MYC (<em>P</em>â€‰=â€‰0.0009) and RRP9 (<em>P</em>â€‰=â€‰0.0165; unpaired t-test). <strong>C</strong> Western blot of c-MYC and RRP9 in MYC knockdown vs. control cells. Expression levels were significantly different for c-MYC (<em>P</em>â€‰=â€‰0.0002) and RRP9 (<em>P</em>â€‰=â€‰0.0180; unpaired t-test). <strong>D</strong>
<em>RRP9</em> mRNA levels in MYC knockdown and control cells treated with actinomycin D over time (0â€‰h, 2â€‰h, 6â€‰h, 8â€‰h) detected by qPCR. <strong>E</strong> Agarose gel electrophoresis showing the size of purified DNA fragments. <strong>F</strong> ChIP-qPCR showing c-MYC enrichment at the RRP9 promoter relative to IgG (<em>P</em>â€‰=â€‰0.0178, unpaired t-test). *<em>P</em>â€‰&lt;â€‰0.05, **<em>P</em>â€‰&lt;â€‰0.01, ***<em>P</em>â€‰&lt;â€‰0.001.</p></figcaption></figure><p id="Par17">Using actinomycin D to assess <em>RRP9</em> mRNA stability, we found that the half-life of <em>RRP9</em> mRNA in the control group was 5.007â€‰hours, whereas MYC knockdown shortened it to 1.341â€‰hours. This result indicates that MYC knockdown accelerates <em>RRP9</em> mRNA degradation and diminishes its stability (Fig. <a href="#Fig4" class="usa-link">4D</a>). To further investigate the relationship between MYC and RRP9, chromatin immunoprecipitation (ChIP) assay was performed. Purified DNA samples analyzed by 2% agarose gel electrophoresis displayed fragments ranging from 150 to 900â€‰bp, confirming effective DNA digestion (Fig. <a href="#Fig4" class="usa-link">4E</a>). Subsequent qPCR analysis of DNA samples (IgG, ChIP, INPUT) using primers targeting the RRP9 promoter region revealed significantly higher c-MYC enrichment at the RRP9 promoter site compared to the IgG control (Fig. <a href="#Fig4" class="usa-link">4F</a>). These findings demonstrate that c-MYC directly binds to the RRP9 promoter sequence, thereby regulating RRP9 expression.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Elevated RRP9 expression is associated with poor prognosis in AML</h3>
<p id="Par18">Our analysis across multiple datasets consistently reveals that high RRP9 expression is a negative prognostic factor in AML. GEPIA2 data analysis demonstrated that high RRP9 expression correlates with poor prognosis in AML patients (Fig. <a href="#Fig5" class="usa-link">5A</a>). Consistently, RNA-seq data from TCGA-LAML revealed that AML patients with elevated RRP9 expression had worse outcomes compared to those with lower expression (Fig. <a href="#Fig5" class="usa-link">5B</a>). Similar findings were observed in additional datasets, including TARGET-AML RNA-seq (Fig. <a href="#MOESM2" class="usa-link">S5D</a>) and microarray datasets GSE37642_GPL570 (Fig. <a href="#MOESM2" class="usa-link">S5E</a>) and GSE12417_GPL96 (Fig. <a href="#MOESM2" class="usa-link">S5F</a>), all linking high RRP9 expression to poor prognosis in AML.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5. Elevated RRP9 expression is associated with poor prognosis in AML.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334614_41419_2025_7928_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af7/12334614/2819db388ee9/41419_2025_7928_Fig5_HTML.jpg" loading="lazy" id="d33e935" height="729" width="789" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> Data from the GEPIA2 website showing that high RRP9 expression in AML patients correlates with poor prognosis (<em>P</em>â€‰=â€‰0.0240, Kaplan Meier analysis), median cutoff. (<strong>B</strong>), TCGA-LAML RNA-seq analysis revealing that high RRP9 expression is associated with poor prognosis in AML (<em>P</em>â€‰=â€‰0.0120, Kaplan Meier analysis). <strong>C</strong>, <strong>D</strong> Western blot analysis revealed elevated RRP9 protein levels in the RRP9 overexpression group compared to the control in Kasumi-1 cells (above, <em>P</em>â€‰=â€‰0.0052, unpaired t-test) and MV4-11 cells (below, <em>P</em>â€‰=â€‰0.0132, unpaired t-test). <strong>E</strong>, <strong>F</strong> RRP9 overexpression significantly enhanced cell proliferation in Kasumi-1 cells (left; 48â€‰h: <em>P</em>â€‰&lt;â€‰0.0001, 72â€‰h: <em>P</em>â€‰=â€‰0.0085, 96â€‰h: <em>P</em>â€‰=â€‰0.0029) and MV4-11 cells (right; 48â€‰h: <em>P</em>â€‰=â€‰0.0051, 72â€‰h: <em>P</em>â€‰&lt;â€‰0.0001, 96â€‰h: <em>P</em>â€‰=â€‰0.0003), as determined by unpaired t-tests. <strong>G</strong>, <strong>H</strong> Overexpression of RRP9 reduced drug sensitivity in Kasumi-1 cells (left; <em>P</em>â€‰&lt;â€‰0.0001 and <em>P</em>â€‰=â€‰0.0008 at two different concentrations) and MV4-11 cells (right; <em>P</em>â€‰=â€‰0.0093, 0.0072, 0.0101 and 0.0062 at four different concentrations), as determined by unpaired t-tests. <strong>I</strong> Flow cytometry analysis showed that RRP9 overexpression enhanced drug resistance in Kasumi-1 cells (<em>P</em>â€‰=â€‰0.0059, unpaired t-test). CTR (control), Chi (chidamide), ARA-C (cytarabine). *<em>P</em>â€‰&lt;â€‰0.05, **<em>P</em>â€‰&lt;â€‰0.01, ***<em>P</em>â€‰&lt;â€‰0.001, ****<em>P</em>â€‰&lt;â€‰0.0001.</p></figcaption></figure><p id="Par19">We further explored the function of RRP9 by generating RRP9-overexpressing cell lines in Kasumi-1 and MV4-11 cells using lentiviral vectors to investigate its role in AML. Western blot analysis confirmed that RRP9 protein levels were significantly elevated in the overexpression group compared to the control in both Kasumi-1 (Fig. <a href="#Fig5" class="usa-link">5C</a>) and MV4-11 cells (Fig. <a href="#Fig5" class="usa-link">5D</a>). To assess the impact of RRP9 overexpression on AML cell proliferation, we performed CCK-8 assays and observed enhanced proliferation in RRP9-overexpressing cells relative to controls in both Kasumi-1 (Fig. <a href="#Fig5" class="usa-link">5E</a>) and MV4-11 cells (Fig. <a href="#Fig5" class="usa-link">5F</a>). Additionally, we evaluated the effect of RRP9 on drug sensitivity by treating the cells with chidamide and cytarabine. The CCK-8 assay revealed reduced toxicity of the combination treatment in RRP9-overexpressing cells, seen in both Kasumi-1 (Fig. <a href="#Fig5" class="usa-link">5G</a>) and MV4-11 cells (Fig. <a href="#Fig5" class="usa-link">5H</a>). Flow cytometry further showed that RRP9 overexpression resulted in less apoptosis following chidamide and cytarabine treatment (Fig. <a href="#Fig5" class="usa-link">5I</a>).</p></section><section id="Sec8"><h3 class="pmc_sec_title">RRP9 regulates ribosome biogenesis in AML cells</h3>
<p id="Par20">We next infected Kasumi-1 cells with lentivirus to generate RRP9 knockdown cell lines. Western blot analysis confirmed a reduction in RRP9 protein levels in the knockdown group (Fig. <a href="#Fig6" class="usa-link">6A</a>). To evaluate the effect of RRP9 knockdown on mature rRNAs (5.8S, 18S, and 28S) abundance in AML cells, we performed qPCR, which revealed significant reductions in these rRNA species (Fig. <a href="#Fig6" class="usa-link">6B</a>). RNA gel electrophoresis further confirmed the decreased abundance of mature rRNAs after RRP9 knockdown (Fig. <a href="#Fig6" class="usa-link">6C</a>).</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6. RRP9 regulates ribosome biogenesis in AML cells.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334614_41419_2025_7928_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af7/12334614/c4b633709d07/41419_2025_7928_Fig6_HTML.jpg" loading="lazy" id="d33e1043" height="882" width="790" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> Western blot analysis showed reduced RRP9 protein levels in the RRP9 knockdown group compared to the control in Kasumi-1 cells, with statistical significance (<em>P</em>â€‰=â€‰0.0290, unpaired t-test). <strong>B</strong> RRP9 knockdown significantly reduced mature rRNA abundance (5.8S: <em>P</em>â€‰=â€‰0.0046, 18S: <em>P</em>â€‰=â€‰0.0012, 28S: <em>P</em>â€‰=â€‰0.0017, unpaired t-tests) in Kasumi-1 cells. <strong>C</strong> RNA gel electrophoresis further confirmed the reduction in mature rRNA levels following RRP9 knockdown. <strong>D</strong> Knockdown of RRP9 significantly reduced the nucleolar area (<em>P</em>â€‰&lt;â€‰0.0001, unpaired t-test) (<em>n</em>â€‰=â€‰15). <strong>E</strong> Immunofluorescence analysis showed that the fluorescence intensity of NPM1 was significantly reduced after RRP9 knockdown (<em>P</em>â€‰&lt;â€‰0.0001, unpaired t-test) (<em>n</em>â€‰=â€‰68). <strong>F</strong> Polysome fractionation assay revealed showing global mRNA translation levels between the control and RRP9 knockdown groups. <strong>G</strong> qPCR analysis of 28S rRNA translation levels across fractions. <strong>H</strong> RRP9 knockdown also decreased nascent protein synthesis (<em>P</em>â€‰=â€‰0.0163, unpaired t-test). MFI Mean fluorescence intensity. *<em>P</em>â€‰&lt;â€‰0.05, **<em>P</em>â€‰&lt;â€‰0.01, ****<em>P</em>â€‰&lt;â€‰0.0001.</p></figcaption></figure><p id="Par21">Additionally, transmission electron microscopy revealed a marked reduction in nucleolus size in the RRP9 knockdown cells (Fig. <a href="#Fig6" class="usa-link">6D</a>). Consistent with this structural change, RRP9 knockdown significantly reduced the fluorescence intensity of NPM1 (Fig. <a href="#Fig6" class="usa-link">6E</a>).</p>
<p id="Par22">The proportion of ribosomes in polysomes is positively correlated with the translation initiation rate [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. Analysis of polysome fractions showed no significant difference in overall mRNA translation levels between the control and RRP9 knockdown cell lines (Fig. <a href="#Fig6" class="usa-link">6F</a>). However, qPCR analysis of specific mRNAs in each polysome fraction showed that 28S rRNA polysome absorbance was significantly reduced in the RRP9-KD group, indicating that RRP9 knockdown resulted in reduced 28S rRNA translation levels in Kasumi-1 cells (Fig. <a href="#Fig6" class="usa-link">6G</a>). Additionally, nascent protein synthesis assays demonstrated that the fluorescence intensity of de novo protein synthesis was significantly lower in the RRP9-knockdown group than in the controls (Fig. <a href="#Fig6" class="usa-link">6H</a>).</p></section><section id="Sec9"><h3 class="pmc_sec_title">Chidamide combined with cytarabine inhibits ribosome biogenesis in AML cells by downregulating RRP9</h3>
<p id="Par23">Based on our findings that chidamide combined with cytarabine inhibits the MYC-RRP9 pathway (Figs. <a href="#Fig3" class="usa-link">3</a> and <a href="#Fig4" class="usa-link">4</a>) and that reduced RRP9 impairs ribosome biogenesis in AML (Fig. <a href="#Fig6" class="usa-link">6</a>), we further examined the effects of this combination on ribosome biogenesis. Western blot showed that the combined treatment more effectively reduced RRP9 protein levels than either chidamide or cytarabine alone in both MV4-11 (Fig. <a href="#Fig7" class="usa-link">7A</a>) and Kasumi-1 cells (Fig. <a href="#Fig7" class="usa-link">7B</a>). RRP9 expression in HL60 cells was also decreased (Fig. <a href="#MOESM2" class="usa-link">S6A</a>). qPCR analysis showed that the abundance of mature rRNAs was reduced after combination treatment in both cell lines (Fig. <a href="#Fig7" class="usa-link">7C</a>, <a href="#Fig7" class="usa-link">D</a>), which was confirmed by RNA gel electrophoresis (Fig. <a href="#Fig7" class="usa-link">7</a>E, <a href="#Fig7" class="usa-link">F</a>). Electron microscopy showed that the nucleolar area was reduced in MV4-11 and Kasumi-1 AML cells following dual-drug treatment (Fig. <a href="#Fig7" class="usa-link">7</a>G, <a href="#Fig7" class="usa-link">H</a>). Immunofluorescence analysis further revealed decreased NPM1 fluorescence intensity in these two cell lines (Fig. <a href="#Fig7" class="usa-link">7</a>I, <a href="#Fig7" class="usa-link">J</a>), with similar results observed in HL60 cells (Fig. <a href="#MOESM2" class="usa-link">S6B</a>). In double-drug-treated MV4-11 cells, an increase in 80S ribosome absorbance compared to the control group was observed (Fig. <a href="#Fig7" class="usa-link">7K</a>), indicating translation arrest. Consistently, nascent protein synthesis assays showed a marked decrease in fluorescence intensity of nascent proteins in Kasumi-1 cells, further supporting this conclusion (Fig. <a href="#Fig7" class="usa-link">7L</a>).</p>
<figure class="fig xbox font-sm" id="Fig7"><h4 class="obj_head">Fig. 7. Chidamide combined with cytarabine inhibits ribosome biogenesis in AML cells by downregulating RRP9.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334614_41419_2025_7928_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af7/12334614/4b728ce0d2de/41419_2025_7928_Fig7_HTML.jpg" loading="lazy" id="d33e1216" height="915" width="790" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong>, <strong>B</strong> Effects of chidamide and cytarabine on RRP9 protein levels in MV4-11 (left, <em>P</em>â€‰=â€‰0.0029) and Kasumi-1 cells (right, <em>P</em>â€‰=â€‰0.0064), showing a significant difference between cytarabine monotherapy and the combination treatment (unpaired t-test). <strong>C</strong>, <strong>D</strong> qPCR analysis showed that treatment with chidamide and cytarabine reduced mature rRNA abundance (5.8S, 18S, and 28S) in MV4-11 cells (left; 5.8S: <em>P</em>â€‰=â€‰0.0078, 18S: <em>P</em>â€‰=â€‰0.0332, 28S: <em>P</em>â€‰=â€‰0.0041) and Kasumi-1 cells (right; 5.8S: <em>P</em>â€‰=â€‰0.0105, 18S: <em>P</em>â€‰=â€‰0.0202, 28S: <em>P</em>â€‰=â€‰0.0115), as determined by unpaired t-tests. <strong>E, F</strong> RNA gel electrophoresis confirmed reduced mature rRNA levels in MV4-11 cells and Kasumi-1 cells after chidamide and cytarabine treatment. <strong>G</strong>, <strong>H</strong> Electron microscopy revealed that treatment with chidamide and cytarabine altered nucleolar morphology in MV4-11 cells (left, <em>P</em>â€‰=â€‰0.0112, unpaired t-test) and Kasumi-1 cells (right, <em>P</em>â€‰=â€‰0.0093, unpaired t-test) (<em>n</em>â€‰=â€‰15). <strong>I, J</strong> Immunofluorescence analysis showed that the fluorescence intensity of NPM1 in MV4-11 cells (left) and Kasumi-1 cells (right) was significantly decreased after treatment with chidamide and cytarabine (<em>P</em>â€‰&lt;â€‰0.0001, unpaired t-test) (<em>n</em>â€‰=â€‰68). <strong>K</strong> Polysome fractionation assay showed an increase in the 80S peak in MV4-11 cells treated with chidamide and cytarabine. <strong>L</strong> The OPP kit and flow cytometry analysis showed a decrease in nascent protein synthesis in Kasumi-1 cells after combination treatment (<em>P</em>â€‰=â€‰0.0221, unpaired t-test). Drug concentrations were 1â€‰ÂµM chidamide and 2â€‰ÂµM cytarabine, administered for 24â€‰h CTR (control), Chi+ARA-C (chidamide + cytarabine). MFI: Mean fluorescence intensity. *<em>P</em>â€‰&lt;â€‰0.05, **<em>P</em>â€‰&lt;â€‰0.01, ****<em>P</em>â€‰&lt;â€‰0.0001.</p></figcaption></figure></section></section><section id="Sec10"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par24">With advances in sequencing technology, our understanding of the molecular mechanisms underlying AML has grown significantly, uncovering genetic and clonal heterogeneity, and laying the groundwork for precision medicine. The introduction of targeted inhibitors for FLT3, IDH1/IDH2, and BCL-2 exemplifies the progress of precision therapies. While these drugs demonstrate moderate anti-leukemia activity when used alone, their clinical efficacy is markedly improved when combined with agents targeting epigenetic or other oncogenic pathways, or traditional cytotoxic treatments [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. This underscores the potential of precision medicine to enhance clinical outcomes for AML patients. Identifying additional therapeutic targets further expands the promise of personalized treatment for AML.</p>
<p id="Par25">In this study, we show that the combination of chidamide and cytarabine exerts a synergistic therapeutic effect against AML, both in vitro and in vivo. This promising approach could represent a significant advancement in the treatment of this aggressive cancer. This finding aligns with previous studies [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>â€“<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>] and further highlights the potential of this combination therapy. Our study demonstrates that chidamide and cytarabine not only jointly suppress the MYC pathway, but also synergistically bind directly to MYC. Zhang et al. demonstrated that MYC is crucial to AML pathogenesis by sustaining the undifferentiated state and self-renewal capacity of leukemic stem cells [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Although no MYC-targeting compounds have yet entered clinical trials, APTO-253, which partially reduces MYC expression, is currently undergoing phase I trials for relapsed or refractory AML or myelodysplastic syndromes (<a href="https://clinicaltrials.gov/ct2/show/NCT02267863" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02267863</a>) [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. These findings suggest an encouraging clinical outlook for MYC inhibition using chidamide in combination with cytarabine for AML.</p>
<p id="Par26">Our studies reveal that MYC serves as an upstream regulator of RRP9. Elevated RRP9 expression is associated with poor prognosis in AML, while decreased RRP9 levels exert therapeutic effects on AML by impairing ribosome biogenesis. These findings underscore the critical role of RRP9 in ribosome biogenesis and highlight its potential as a target for cancer therapy. Cancer cells often upregulate ribosome biogenesis to meet increased protein synthesis demands [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>], and targeting this process has emerged as a promising therapeutic strategy [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>, <a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. In AML, enhanced translation initiation has been shown to promote tumor growth [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>], while inhibitors of protein translation effectively target leukemic cells [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. Moreover, reduced protein synthesis and ribosome instability can trigger apoptosis in leukemic cells [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. Together, these insights position RRP9 as a key player in ribosome biogenesis and a promising target for AML therapy.</p>
<p id="Par27">Finally, we found that the combination of chidamide and cytarabine synergistically suppresses ribosome biogenesis in AML cells by downregulating RRP9. This finding underscores the significance of targeting key oncoproteins and critical signaling pathways, paving the way for optimizing AML treatment strategies through combination therapies. Further research is required to fully understand the molecular interactions and refine the clinical application of this promising approach. However, this study has some limitations. We mainly focused on the MYC-RRP9-ribosome biogenesis axis. Whether it relates to known mechanisms of chidamide and cytarabine or represents a novel pathway needs further study.</p>
<p id="Par28">In conclusion, this study offers a more comprehensive understanding of the synergistic therapeutic effects and underlying mechanisms of chidamide combined with cytarabine in AML, both in vitro and in vivo. The combination of chidamide and cytarabine induces AML cell death by inhibiting ribosome biogenesis through downregulation of the MYC-RRP9 pathway.</p></section><section id="Sec11"><h2 class="pmc_sec_title">Materials and Methods</h2>
<section id="Sec12"><h3 class="pmc_sec_title">Cell lines and reagents</h3>
<p id="Par29">The AML cell lines MV4-11, Kasumi-1, and HL60 were obtained from ATCC (Manassas, VA, USA). Their authenticity was confirmed by STR profiling, and all experiments used mycoplasma-free cultures.</p>
<p id="Par30">Chidamide was provided by Chipscreen Biosciences (Shenzhen, China). Cytarabine, puromycin 2HCl, and 10058-F4 were purchased from Selleck Chemicals (Houston, USA), and MG132 from Meilun Biotech (Dalian, China).</p></section><section id="Sec13"><h3 class="pmc_sec_title">SPR assay</h3>
<p id="Par31">For SPR measurements, c-MYC protein (RayBiotech, USA) was dissolved in double-distilled water, diluted to 25â€‰Î¼g/ml with sodium acetate buffer (pH4.5), and immobilized on a CM5 chip (â€‰~â€‰4000 RU) with a blank channel as control. Chidamide was applied at concentrations from 13.7â€‰nM to 10â€‰Î¼M over immobilized c-MYC at 30â€‰Î¼l/min, and binding was recorded. Kinetic analysis and Kd determination were performed using a Biacore X100 with the Steady-State Affinity model. For synergy experiments, cytarabine was prepared in buffer at a concentration of 10â€‰Î¼M. To validate the docking sites, a recombinant MYC protein carrying the predicted substitutions (P406A, V409A, K413A, A416G) was obtained from MedChemExpress (HY-P7S1056, USA).</p></section><section id="Sec14"><h3 class="pmc_sec_title">Other Methods</h3>
<p id="Par32">The detailed protocols for MTT assays, flow cytometry, western blot (all full-length and uncropped blots are shown in Fig. <a href="#MOESM1" class="usa-link">S7</a>), mononuclear cell isolation, CCK-8 assays, animal studies, RNA-seq, qPCR, gene expression-prognosis link in AML, molecular docking, MD simulations, lentivirus construction and infection, mRNA stability assay, ChIP assay, RNA gel electrophoresis, electron microscopy observation of nucleoli, immunofluorescence, polysome fractionation assay [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>], and nascent protein detection assays can be found in the Supplemental Materials and Methods. RNA-seq coverage and quality statistics are shown in Table <a href="#MOESM2" class="usa-link">S5</a>. qPCR primer sequences for 5.8S, 18S, 28S rRNA [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>], RRP9 promoter, NOP16, NOP56, and DDX21 are provided in Table <a href="#MOESM2" class="usa-link">S6</a>.</p></section><section id="Sec15"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par33">Data are shown as meanâ€‰Â±â€‰standard deviation. Western blot and immunofluorescence were quantified with ImageJ, and statistical analysis was performed using GraphPad Prism 8.0. t-tests were used, with <em>P</em>&lt;â€‰0.05 considered significant (*).</p></section></section><section id="Sec16"><h2 class="pmc_sec_title">Supplementary information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12334614/bin/41419_2025_7928_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Fig.S7_wb</a><sup> (14MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12334614/bin/41419_2025_7928_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplemental Material</a><sup> (3.4MB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>This research was supported by the National Natural Science Foundation of China (grant 82370171) and the Science and Technology Department of Sichuan Province (grant 2022YFS0191). We would like to thank Liyuan Fang from the Genomics Center, Core Facilities of West China Hospital, Sichuan University, for assisting with cell line identification. We sincerely appreciate Jingyao Zhang from the Core Facilities of West China Hospital, Sichuan University for helping us perform SPR studies.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Qing Li: conceptualization, data curation, formal analysis, methodology, investigation, visualization, resources, software, validation, writingâ€”original draft, and writingâ€”review &amp; editing. Fangfang Wang: conceptualization, methodology, and visualization. Xinrong Xiang, Lei Zhao, and Yu Liu: methodology and visualization. Xuefeng Li, Ying Qu, Jingcao Huang, Yunfan Yang, Yang Dai, Xiao Shuai, Jiazhuo Liu, and Jie Huang: visualization. Yu Wu: conceptualization, funding acquisition, investigation, methodology, resources, supervision, visualization, and writingâ€”review &amp; editing.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This work was supported by the National Natural Science Foundation of China [grant numbers 82370171]; the Department of Science and Technology of Sichuan Provincial [grant number 2022YFS0191].</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The Raw and normalized RNA-seq data generated in this study are publicly available in Gene Expression Omnibus under accession number <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE231914" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE231914</a> (<a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE231914" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE231914</a>). All other data are available in the main text or supplementary materials.</p></section><section id="FPar1"><h2 class="pmc_sec_title">Competing interests</h2>
<p id="Par34">The authors declare no competing interests.</p></section><section id="FPar2"><h2 class="pmc_sec_title">Ethical approval</h2>
<p id="Par35">The extraction of primary AML cells was approved by the Ethics Committee of West China Hospital, Sichuan University (approval number: 2019 (114)). The animal experiments were approved by the Ethics Committee of West China Hospital, Sichuan University (approval number: 2020232â€‰A). All methods involving human samples and animals were performed in accordance with the relevant guidelines and regulations.</p></section><section id="FPar3"><h2 class="pmc_sec_title">Informed consent</h2>
<p id="Par36">All human-related experiments in this study, including the use of human tissue samples, were conducted with the written informed consent of all participants or sample donors.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1"><p>Edited by Dr. Gemma Kelly</p></div>
<div class="fn p" id="fn2"><p><strong>Publisherâ€™s note</strong> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div>
</div></section><section id="sec17"><h2 class="pmc_sec_title">Supplementary information</h2>
<p>The online version contains supplementary material available at 10.1038/s41419-025-07928-y.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Sasaki K, Ravandi F, Kadia TM, DiNardo CD, Short NJ, Borthakur G, et al. De novo acute myeloid leukemia: A population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017. Cancer. 2021;127:2049â€“61.
</cite> [<a href="https://doi.org/10.1002/cncr.33458" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11826308/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33818756/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sasaki%20K,%20Ravandi%20F,%20Kadia%20TM,%20DiNardo%20CD,%20Short%20NJ,%20Borthakur%20G,%20et%20al.%20De%20novo%20acute%20myeloid%20leukemia:%20A%20population-based%20study%20of%20outcome%20in%20the%20United%20States%20based%20on%20the%20Surveillance,%20Epidemiology,%20and%20End%20Results%20(SEER)%20database,%201980%20to%202017.%20Cancer.%202021;127:2049%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Shimony S, Stahl M, Stone RM. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023;98:502â€“26.
</cite> [<a href="https://doi.org/10.1002/ajh.26822" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36594187/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shimony%20S,%20Stahl%20M,%20Stone%20RM.%20Acute%20myeloid%20leukemia:%202023%20update%20on%20diagnosis,%20risk-stratification,%20and%20management.%20Am%20J%20Hematol.%202023;98:502%E2%80%9326." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Forsberg M, Konopleva M. AML treatment: conventional chemotherapy and emerging novel agents. Trends Pharm Sci. 2024;45:430â€“48.
</cite> [<a href="https://doi.org/10.1016/j.tips.2024.03.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38643058/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Forsberg%20M,%20Konopleva%20M.%20AML%20treatment:%20conventional%20chemotherapy%20and%20emerging%20novel%20agents.%20Trends%20Pharm%20Sci.%202024;45:430%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Wang H, Mao L, Yang M, Qian P, Lu H, Tong H, et al. Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial. Lancet Haematol. 2022;9:e415â€“e424.
</cite> [<a href="https://doi.org/10.1016/S2352-3026(22)00106-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35512726/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20H,%20Mao%20L,%20Yang%20M,%20Qian%20P,%20Lu%20H,%20Tong%20H,%20et%20al.%20Venetoclax%20plus%203%20+%207%20daunorubicin%20and%20cytarabine%20chemotherapy%20as%20first-line%20treatment%20for%20adults%20with%20acute%20myeloid%20leukaemia:%20a%20multicentre,%20single-arm,%20phase%202%20trial.%20Lancet%20Haematol.%202022;9:e415%E2%80%93e424." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Erba HP, Montesinos P, Kim HJ, Patkowska E, Vrhovac R, Zak P, et al. Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;401:1571â€“83.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(23)00464-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37116523/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Erba%20HP,%20Montesinos%20P,%20Kim%20HJ,%20Patkowska%20E,%20Vrhovac%20R,%20Zak%20P,%20et%20al.%20Quizartinib%20plus%20chemotherapy%20in%20newly%20diagnosed%20patients%20with%20FLT3-internal-tandem-duplication-positive%20acute%20myeloid%20leukaemia%20(QuANTUM-First):%20a%20randomised,%20double-blind,%20placebo-controlled,%20phase%203%20trial.%20Lancet.%202023;401:1571%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Venugopal S, Sekeres MA. Contemporary Management of Acute Myeloid Leukemia: A Review. JAMA Oncol. 2024;10:1417â€“25.
</cite> [<a href="https://doi.org/10.1001/jamaoncol.2024.2662" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39115831/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Venugopal%20S,%20Sekeres%20MA.%20Contemporary%20Management%20of%20Acute%20Myeloid%20Leukemia:%20A%20Review.%20JAMA%20Oncol.%202024;10:1417%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Lu G, Jin S, Lin S, Gong Y, Zhang L, Yang J, et al. Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL). Clin Epigenetics. 2023;15:124.
</cite> [<a href="https://doi.org/10.1186/s13148-023-01531-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10398948/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37533111/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lu%20G,%20Jin%20S,%20Lin%20S,%20Gong%20Y,%20Zhang%20L,%20Yang%20J,%20et%20al.%20Update%20on%20histone%20deacetylase%20inhibitors%20in%20peripheral%20T-cell%20lymphoma%20(PTCL).%20Clin%20Epigenetics.%202023;15:124." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Li X, Yan X, Guo W, Huang X, Huang J, Yu M, et al. Chidamide in FLT3-ITD positive acute myeloid leukemia and the synergistic effect in combination with cytarabine. Biomed Pharmacother. 2017;90:699â€“704.
</cite> [<a href="https://doi.org/10.1016/j.biopha.2017.04.037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28419965/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20X,%20Yan%20X,%20Guo%20W,%20Huang%20X,%20Huang%20J,%20Yu%20M,%20et%20al.%20Chidamide%20in%20FLT3-ITD%20positive%20acute%20myeloid%20leukemia%20and%20the%20synergistic%20effect%20in%20combination%20with%20cytarabine.%20Biomed%20Pharmacother.%202017;90:699%E2%80%93704." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Li Y, Wang Y, Zhou Y, Li J, Chen K, Zhang L, et al. Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells. Clin Epigenetics. 2017;9:83.
</cite> [<a href="https://doi.org/10.1186/s13148-017-0377-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5556349/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28814980/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20Y,%20Wang%20Y,%20Zhou%20Y,%20Li%20J,%20Chen%20K,%20Zhang%20L,%20et%20al.%20Cooperative%20effect%20of%20chidamide%20and%20chemotherapeutic%20drugs%20induce%20apoptosis%20by%20DNA%20damage%20accumulation%20and%20repair%20defects%20in%20acute%20myeloid%20leukemia%20stem%20and%20progenitor%20cells.%20Clin%20Epigenetics.%202017;9:83." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Huang H, Wenbing Y, Dong A, He Z, Yao R, Guo W. Chidamide Enhances the Cytotoxicity of Cytarabine and Sorafenib in Acute Myeloid Leukemia Cells by Modulating H3K9me3 and Autophagy Levels. Front Oncol. 2019;9:1276.
</cite> [<a href="https://doi.org/10.3389/fonc.2019.01276" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6901797/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31850196/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20H,%20Wenbing%20Y,%20Dong%20A,%20He%20Z,%20Yao%20R,%20Guo%20W.%20Chidamide%20Enhances%20the%20Cytotoxicity%20of%20Cytarabine%20and%20Sorafenib%20in%20Acute%20Myeloid%20Leukemia%20Cells%20by%20Modulating%20H3K9me3%20and%20Autophagy%20Levels.%20Front%20Oncol.%202019;9:1276." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Wei Y, Wang L, Zhu C, Li H, Bo J, Zhang R, et al. A phase II study of chidamide, cytarabine, aclarubicin, granulocyte colony-stimulating factor, and donor lymphocyte infusion for relapsed acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation. Med Oncol. 2023;40:77.
</cite> [<a href="https://doi.org/10.1007/s12032-022-01911-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9832090/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36625951/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wei%20Y,%20Wang%20L,%20Zhu%20C,%20Li%20H,%20Bo%20J,%20Zhang%20R,%20et%20al.%20A%20phase%20II%20study%20of%20chidamide,%20cytarabine,%20aclarubicin,%20granulocyte%20colony-stimulating%20factor,%20and%20donor%20lymphocyte%20infusion%20for%20relapsed%20acute%20myeloid%20leukemia%20and%20myelodysplastic%20syndrome%20after%20allogeneic%20hematopoietic%20stem%20cell%20transplantation.%20Med%20Oncol.%202023;40:77." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Wang L, Luo J, Chen G, Fang M, Wei X, Li Y, et al. Chidamide, decitabine, cytarabine, aclarubicin, and granulocyte colony-stimulating factor (CDCAG) in patients with relapsed/refractory acute myeloid leukemia: a single-arm, phase 1/2 study. Clin Epigenetics. 2020;12:132.
</cite> [<a href="https://doi.org/10.1186/s13148-020-00923-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7466805/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32873343/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20L,%20Luo%20J,%20Chen%20G,%20Fang%20M,%20Wei%20X,%20Li%20Y,%20et%20al.%20Chidamide,%20decitabine,%20cytarabine,%20aclarubicin,%20and%20granulocyte%20colony-stimulating%20factor%20(CDCAG)%20in%20patients%20with%20relapsed/refractory%20acute%20myeloid%20leukemia:%20a%20single-arm,%20phase%201/2%20study.%20Clin%20Epigenetics.%202020;12:132." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Catez F, Dalla Venezia N, Marcel V, Zorbas C, Lafontaine DLJ, Diaz JJ. Ribosome biogenesis: An emerging druggable pathway for cancer therapeutics. Biochem Pharm. 2019;159:74â€“81.
</cite> [<a href="https://doi.org/10.1016/j.bcp.2018.11.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30468711/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Catez%20F,%20Dalla%20Venezia%20N,%20Marcel%20V,%20Zorbas%20C,%20Lafontaine%20DLJ,%20Diaz%20JJ.%20Ribosome%20biogenesis:%20An%20emerging%20druggable%20pathway%20for%20cancer%20therapeutics.%20Biochem%20Pharm.%202019;159:74%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Elhamamsy AR, Metge BJ, Alsheikh HA, Shevde LA, Samant RS. Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance. Cancer Res. 2022;82:2344â€“53.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-21-4087" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9256764/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35303060/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Elhamamsy%20AR,%20Metge%20BJ,%20Alsheikh%20HA,%20Shevde%20LA,%20Samant%20RS.%20Ribosome%20Biogenesis:%20A%20Central%20Player%20in%20Cancer%20Metastasis%20and%20Therapeutic%20Resistance.%20Cancer%20Res.%202022;82:2344%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Zang Y, Ran X, Yuan J, Wu H, Wang Y, Li H, et al. Genomic hallmarks and therapeutic targets of ribosome biogenesis in cancer. Brief Bioinform. 2024;25:bbae023.
</cite> [<a href="https://doi.org/10.1093/bib/bbae023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10859687/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38343327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zang%20Y,%20Ran%20X,%20Yuan%20J,%20Wu%20H,%20Wang%20Y,%20Li%20H,%20et%20al.%20Genomic%20hallmarks%20and%20therapeutic%20targets%20of%20ribosome%20biogenesis%20in%20cancer.%20Brief%20Bioinform.%202024;25:bbae023." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Garcia-Cuellar MP, Prinz A, Slany RK. Meis1 supports leukemogenesis through stimulation of ribosomal biogenesis and Myc. Haematologica. 2022;107:2601â€“16.
</cite> [<a href="https://doi.org/10.3324/haematol.2022.280831" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9614532/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35546301/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Garcia-Cuellar%20MP,%20Prinz%20A,%20Slany%20RK.%20Meis1%20supports%20leukemogenesis%20through%20stimulation%20of%20ribosomal%20biogenesis%20and%20Myc.%20Haematologica.%202022;107:2601%E2%80%9316." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Xu J, Zhong A, Zhang S, Chen M, Zhang L, Hang X, et al. KMT2D Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis Inhibition. Adv Sci (Weinh). 2023;10:e2206098.
</cite> [<a href="https://doi.org/10.1002/advs.202206098" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10323629/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37142882/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20J,%20Zhong%20A,%20Zhang%20S,%20Chen%20M,%20Zhang%20L,%20Hang%20X,%20et%20al.%20KMT2D%20Deficiency%20Promotes%20Myeloid%20Leukemias%20which%20Is%20Vulnerable%20to%20Ribosome%20Biogenesis%20Inhibition.%20Adv%20Sci%20(Weinh).%202023;10:e2206098." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Lafita-Navarro MC, Conacci-Sorrell M. Nucleolar stress: From development to cancer. Semin Cell Dev Biol. 2023;136:64â€“74.
</cite> [<a href="https://doi.org/10.1016/j.semcdb.2022.04.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9883801/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35410715/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lafita-Navarro%20MC,%20Conacci-Sorrell%20M.%20Nucleolar%20stress:%20From%20development%20to%20cancer.%20Semin%20Cell%20Dev%20Biol.%202023;136:64%E2%80%9374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Grisendi S, Mecucci C, Falini B, Pandolfi PP. Nucleophosmin and cancer. Nat Rev Cancer. 2006;6:493â€“505.
</cite> [<a href="https://doi.org/10.1038/nrc1885" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16794633/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Grisendi%20S,%20Mecucci%20C,%20Falini%20B,%20Pandolfi%20PP.%20Nucleophosmin%20and%20cancer.%20Nat%20Rev%20Cancer.%202006;6:493%E2%80%93505." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Pelletier J, Thomas G, Volarevic S. Ribosome biogenesis in cancer: new players and therapeutic avenues. Nat Rev Cancer. 2018;18:51â€“63.
</cite> [<a href="https://doi.org/10.1038/nrc.2017.104" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29192214/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pelletier%20J,%20Thomas%20G,%20Volarevic%20S.%20Ribosome%20biogenesis%20in%20cancer:%20new%20players%20and%20therapeutic%20avenues.%20Nat%20Rev%20Cancer.%202018;18:51%E2%80%9363." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Ojha S, Malla S, Lyons SM. snoRNPs: Functions in Ribosome Biogenesis. Biomolecules. 2020;10:783.
</cite> [<a href="https://doi.org/10.3390/biom10050783" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7277114/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32443616/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ojha%20S,%20Malla%20S,%20Lyons%20SM.%20snoRNPs:%20Functions%20in%20Ribosome%20Biogenesis.%20Biomolecules.%202020;10:783." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Clerget G, Bourguignon-Igel V, Marmier-Gourrier N, Rolland N, Wacheul L, Manival X, et al. Synergistic defects in pre-rRNA processing from mutations in the U3-specific protein Rrp9 and U3 snoRNA. Nucleic Acids Res. 2020;48:3848â€“68.
</cite> [<a href="https://doi.org/10.1093/nar/gkaa066" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7144924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31996908/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Clerget%20G,%20Bourguignon-Igel%20V,%20Marmier-Gourrier%20N,%20Rolland%20N,%20Wacheul%20L,%20Manival%20X,%20et%20al.%20Synergistic%20defects%20in%20pre-rRNA%20processing%20from%20mutations%20in%20the%20U3-specific%20protein%20Rrp9%20and%20U3%20snoRNA.%20Nucleic%20Acids%20Res.%202020;48:3848%E2%80%9368." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47:W556â€“W560.
</cite> [<a href="https://doi.org/10.1093/nar/gkz430" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6602440/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31114875/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tang%20Z,%20Kang%20B,%20Li%20C,%20Chen%20T,%20Zhang%20Z.%20GEPIA2:%20an%20enhanced%20web%20server%20for%20large-scale%20expression%20profiling%20and%20interactive%20analysis.%20Nucleic%20Acids%20Res.%202019;47:W556%E2%80%93W560." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Mill CP, Fiskus W, DiNardo CD, Birdwell C, Davis JA, Kadia TM, et al. Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2. Blood. 2022;139:907â€“21.
</cite> [<a href="https://doi.org/10.1182/blood.2021013156" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8832475/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34601571/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mill%20CP,%20Fiskus%20W,%20DiNardo%20CD,%20Birdwell%20C,%20Davis%20JA,%20Kadia%20TM,%20et%20al.%20Effective%20therapy%20for%20AML%20with%20RUNX1%20mutation%20by%20cotreatment%20with%20inhibitors%20of%20protein%20translation%20and%20BCL2.%20Blood.%202022;139:907%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Han Y, Hu A, Qu Y, Xu Q, Wang H, Feng Y, et al. Covalent targeting the LAS1-NOL9 axis for selective treatment in NPM1 mutant acute myeloid leukemia. Pharmacol Res. 2023;189:106700.
</cite> [<a href="https://doi.org/10.1016/j.phrs.2023.106700" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36796466/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Han%20Y,%20Hu%20A,%20Qu%20Y,%20Xu%20Q,%20Wang%20H,%20Feng%20Y,%20et%20al.%20Covalent%20targeting%20the%20LAS1-NOL9%20axis%20for%20selective%20treatment%20in%20NPM1%20mutant%20acute%20myeloid%20leukemia.%20Pharmacol%20Res.%202023;189:106700." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Khot A, Brajanovski N, Cameron DP, Hein N, Maclachlan KH, Sanij E, et al. First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study. Cancer Discov. 2019;9:1036â€“49.
</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-18-1455" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31092402/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Khot%20A,%20Brajanovski%20N,%20Cameron%20DP,%20Hein%20N,%20Maclachlan%20KH,%20Sanij%20E,%20et%20al.%20First-in-Human%20RNA%20Polymerase%20I%20Transcription%20Inhibitor%20CX-5461%20in%20Patients%20with%20Advanced%20Hematologic%20Cancers:%20Results%20of%20a%20Phase%20I%20Dose-Escalation%20Study.%20Cancer%20Discov.%202019;9:1036%E2%80%9349." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Destefanis F, Manara V, Bellosta P. Myc as a Regulator of Ribosome Biogenesis and Cell Competition: A Link to Cancer. Int J Mol Sci. 2020;21:4037.
</cite> [<a href="https://doi.org/10.3390/ijms21114037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7312820/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32516899/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Destefanis%20F,%20Manara%20V,%20Bellosta%20P.%20Myc%20as%20a%20Regulator%20of%20Ribosome%20Biogenesis%20and%20Cell%20Competition:%20A%20Link%20to%20Cancer.%20Int%20J%20Mol%20Sci.%202020;21:4037." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>van Riggelen J, Yetil A, Felsher DW. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer. 2010;10:301â€“9.
</cite> [<a href="https://doi.org/10.1038/nrc2819" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20332779/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?van%20Riggelen%20J,%20Yetil%20A,%20Felsher%20DW.%20MYC%20as%20a%20regulator%20of%20ribosome%20biogenesis%20and%20protein%20synthesis.%20Nat%20Rev%20Cancer.%202010;10:301%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Amaya ML, Inguva A, Pei S, Jones C, Krug A, Ye H, et al. The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation. Blood. 2022;139:584â€“96.
</cite> [<a href="https://doi.org/10.1182/blood.2021013201" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8796651/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34525179/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Amaya%20ML,%20Inguva%20A,%20Pei%20S,%20Jones%20C,%20Krug%20A,%20Ye%20H,%20et%20al.%20The%20STAT3-MYC%20axis%20promotes%20survival%20of%20leukemia%20stem%20cells%20by%20regulating%20SLC1A5%20and%20oxidative%20phosphorylation.%20Blood.%202022;139:584%E2%80%9396." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Marquardt V, Theruvath J, Pauck D, Picard D, Qin N, Blumel L, et al. Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation. J Immunother Cancer. 2023;11:e005871.
</cite> [<a href="https://doi.org/10.1136/jitc-2022-005871" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9843227/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36639156/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Marquardt%20V,%20Theruvath%20J,%20Pauck%20D,%20Picard%20D,%20Qin%20N,%20Blumel%20L,%20et%20al.%20Tacedinaline%20(CI-994),%20a%20class%20I%20HDAC%20inhibitor,%20targets%20intrinsic%20tumor%20growth%20and%20leptomeningeal%20dissemination%20in%20MYC-driven%20medulloblastoma%20while%20making%20them%20susceptible%20to%20anti-CD47-induced%20macrophage%20phagocytosis%20via%20NF-kB-TGM2%20driven%20tumor%20inflammation.%20J%20Immunother%20Cancer.%202023;11:e005871." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Warner JR, Knopf PM, Rich A. A multiple ribosomal structure in protein synthesis. Proc Natl Acad Sci USA. 1963;49:122â€“9.
</cite> [<a href="https://doi.org/10.1073/pnas.49.1.122" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC300639/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/13998950/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Warner%20JR,%20Knopf%20PM,%20Rich%20A.%20A%20multiple%20ribosomal%20structure%20in%20protein%20synthesis.%20Proc%20Natl%20Acad%20Sci%20USA.%201963;49:122%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Dohner H, Wei AH, Lowenberg B. Towards precision medicine for AML. Nat Rev Clin Oncol. 2021;18:577â€“90.
</cite> [<a href="https://doi.org/10.1038/s41571-021-00509-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34006997/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dohner%20H,%20Wei%20AH,%20Lowenberg%20B.%20Towards%20precision%20medicine%20for%20AML.%20Nat%20Rev%20Clin%20Oncol.%202021;18:577%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Zhao H, Jiang Y, Lin F, Zhong M, Tan J, Zhou Y, et al. Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells. Exp Hematol Oncol. 2022;11:29.
</cite> [<a href="https://doi.org/10.1186/s40164-022-00282-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9112613/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35581670/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20H,%20Jiang%20Y,%20Lin%20F,%20Zhong%20M,%20Tan%20J,%20Zhou%20Y,%20et%20al.%20Chidamide%20and%20apatinib%20are%20therapeutically%20synergistic%20in%20acute%20myeloid%20leukemia%20stem%20and%20progenitor%20cells.%20Exp%20Hematol%20Oncol.%202022;11:29." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Gu S, Hou Y, Dovat K, Dovat S, Song C, Ge Z. Synergistic effect of HDAC inhibitor Chidamide with Cladribine on cell cycle arrest and apoptosis by targeting HDAC2/c-Myc/RCC1 axis in acute myeloid leukemia. Exp Hematol Oncol. 2023;12:23.
</cite> [<a href="https://doi.org/10.1186/s40164-023-00383-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9972767/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36849955/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gu%20S,%20Hou%20Y,%20Dovat%20K,%20Dovat%20S,%20Song%20C,%20Ge%20Z.%20Synergistic%20effect%20of%20HDAC%20inhibitor%20Chidamide%20with%20Cladribine%20on%20cell%20cycle%20arrest%20and%20apoptosis%20by%20targeting%20HDAC2/c-Myc/RCC1%20axis%20in%20acute%20myeloid%20leukemia.%20Exp%20Hematol%20Oncol.%202023;12:23." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Lin L, Que Y, Lu P, Li H, Xiao M, Zhu X, et al. Chidamide Inhibits Acute Myeloid Leukemia Cell Proliferation by lncRNA VPS9D1-AS1 Downregulation via MEK/ERK Signaling Pathway. Front Pharm. 2020;11:569651.</cite> [<a href="https://doi.org/10.3389/fphar.2020.569651" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7604502/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33192510/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lin%20L,%20Que%20Y,%20Lu%20P,%20Li%20H,%20Xiao%20M,%20Zhu%20X,%20et%20al.%20Chidamide%20Inhibits%20Acute%20Myeloid%20Leukemia%20Cell%20Proliferation%20by%20lncRNA%20VPS9D1-AS1%20Downregulation%20via%20MEK/ERK%20Signaling%20Pathway.%20Front%20Pharm.%202020;11:569651." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Zhang L, Li J, Xu H, Shao X, Fu L, Hou Y, et al. Myc-Miz1 signaling promotes self-renewal of leukemia stem cells by repressing Cebpalpha and Cebpdelta. Blood. 2020;135:1133â€“45.
</cite> [<a href="https://doi.org/10.1182/blood.2019001863" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9981456/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32040550/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20L,%20Li%20J,%20Xu%20H,%20Shao%20X,%20Fu%20L,%20Hou%20Y,%20et%20al.%20Myc-Miz1%20signaling%20promotes%20self-renewal%20of%20leukemia%20stem%20cells%20by%20repressing%20Cebpalpha%20and%20Cebpdelta.%20Blood.%202020;135:1133%E2%80%9345." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Duffy MJ, Oâ€™Grady S, Tang M, Crown J. MYC as a target for cancer treatment. Cancer Treat Rev. 2021;94:102154.
</cite> [<a href="https://doi.org/10.1016/j.ctrv.2021.102154" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33524794/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Duffy%20MJ,%20O%E2%80%99Grady%20S,%20Tang%20M,%20Crown%20J.%20MYC%20as%20a%20target%20for%20cancer%20treatment.%20Cancer%20Treat%20Rev.%202021;94:102154." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Jiao L, Liu Y, Yu XY, Pan X, Zhang Y, Tu J, et al. Ribosome biogenesis in disease: new players and therapeutic targets. Signal Transduct Target Ther. 2023;8:15.
</cite> [<a href="https://doi.org/10.1038/s41392-022-01285-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9826790/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36617563/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jiao%20L,%20Liu%20Y,%20Yu%20XY,%20Pan%20X,%20Zhang%20Y,%20Tu%20J,%20et%20al.%20Ribosome%20biogenesis%20in%20disease:%20new%20players%20and%20therapeutic%20targets.%20Signal%20Transduct%20Target%20Ther.%202023;8:15." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Kovalski JR, Kuzuoglu-Ozturk D, Ruggero D. Protein synthesis control in cancer: selectivity and therapeutic targeting. EMBO J. 2022;41:e109823.
</cite> [<a href="https://doi.org/10.15252/embj.2021109823" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9016353/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35315941/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kovalski%20JR,%20Kuzuoglu-Ozturk%20D,%20Ruggero%20D.%20Protein%20synthesis%20control%20in%20cancer:%20selectivity%20and%20therapeutic%20targeting.%20EMBO%20J.%202022;41:e109823." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Sun L, Wang W, Han C, Huang W, Sun Y, Fang K, et al. The oncomicropeptide APPLE promotes hematopoietic malignancy by enhancing translation initiation. Mol Cell. 2021;81:4493â€“508.
</cite> [<a href="https://doi.org/10.1016/j.molcel.2021.08.033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34555354/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun%20L,%20Wang%20W,%20Han%20C,%20Huang%20W,%20Sun%20Y,%20Fang%20K,%20et%20al.%20The%20oncomicropeptide%20APPLE%20promotes%20hematopoietic%20malignancy%20by%20enhancing%20translation%20initiation.%20Mol%20Cell.%202021;81:4493%E2%80%93508." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Messling JE, Agger K, Andersen KL, Kromer K, Kuepper HM, Lund AH, et al. Targeting RIOK2 ATPase activity leads to decreased protein synthesis and cell death in acute myeloid leukemia. Blood. 2022;139:245â€“55.
</cite> [<a href="https://doi.org/10.1182/blood.2021012629" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8759535/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34359076/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Messling%20JE,%20Agger%20K,%20Andersen%20KL,%20Kromer%20K,%20Kuepper%20HM,%20Lund%20AH,%20et%20al.%20Targeting%20RIOK2%20ATPase%20activity%20leads%20to%20decreased%20protein%20synthesis%20and%20cell%20death%20in%20acute%20myeloid%20leukemia.%20Blood.%202022;139:245%E2%80%9355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Gandin V, Sikstrom K, Alain T, Morita M, McLaughlan S, Larsson O, et al. Polysome fractionation and analysis of mammalian translatomes on a genome-wide scale. J Vis Exp. 2014;87:51455.</cite> [<a href="https://doi.org/10.3791/51455" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4189431/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24893926/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gandin%20V,%20Sikstrom%20K,%20Alain%20T,%20Morita%20M,%20McLaughlan%20S,%20Larsson%20O,%20et%20al.%20Polysome%20fractionation%20and%20analysis%20of%20mammalian%20translatomes%20on%20a%20genome-wide%20scale.%20J%20Vis%20Exp.%202014;87:51455." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Sergeeva O, Sergeev P, Melnikov P, Prikazchikova T, Dontsova O, Zatsepin T. Modification of Adenosine196 by Mettl3 Methyltransferase in the 5â€™-External Transcribed Spacer of 47S Pre-rRNA Affects rRNA Maturation. Cells. 2020;9:1061.
</cite> [<a href="https://doi.org/10.3390/cells9041061" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7226171/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32344536/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sergeeva%20O,%20Sergeev%20P,%20Melnikov%20P,%20Prikazchikova%20T,%20Dontsova%20O,%20Zatsepin%20T.%20Modification%20of%20Adenosine196%20by%20Mettl3%20Methyltransferase%20in%20the%205%E2%80%99-External%20Transcribed%20Spacer%20of%2047S%20Pre-rRNA%20Affects%20rRNA%20Maturation.%20Cells.%202020;9:1061." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12334614/bin/41419_2025_7928_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Fig.S7_wb</a><sup> (14MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12334614/bin/41419_2025_7928_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplemental Material</a><sup> (3.4MB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The Raw and normalized RNA-seq data generated in this study are publicly available in Gene Expression Omnibus under accession number <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE231914" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE231914</a> (<a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE231914" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE231914</a>). All other data are available in the main text or supplementary materials.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Cell Death &amp; Disease are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s41419-025-07928-y"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/41419_2025_Article_7928.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.8Â MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12334614/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12334614/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12334614%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334614/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12334614/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12334614/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40781078/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12334614/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40781078/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12334614/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12334614/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="fU0spQeoAK4ZNUh9UVqOglqDEIiqh7A6PAmeeFwHe9uDa1nT8mbRPy42XQHuqGgI">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
